By tracking patent expirations, patent litigation, generic and biosimilar development, you can anticipate these market-shaping forces and stay one step ahead.
DrugPatentWatch Database Preview
Sodium nitroprusside - Generic Drug Details
What are the generic drug sources for sodium nitroprusside and what is the scope of patent protection?
Sodium nitroprusside
is the generic ingredient in four branded drugs marketed by Roche, Abbott, Abbvie, Hospira, Abraxis Pharm, Akorn, Amneal, Amphastar Pharms Inc, Aurobindo Pharma Ltd, Baxter Hlthcare, Cipla, Dr Reddys Labs Ltd, Hainan Poly Pharm, Hong Kong, Medicure, Micro Labs, Mylan Labs Ltd, Nexus Pharms, Sagent Pharms Inc, Somerset Theraps Llc, Sun Pharm, Teva Parenteral, Virtus Pharm, Xiromed, and Exela Pharma, and is included in twenty-six NDAs. Additional information is available in the individual branded drug profile pages.There are one thousand four hundred and seventy-two drug master file entries for sodium nitroprusside. Fourteen suppliers are listed for this compound.
Summary for sodium nitroprusside
| US Patents: | 0 |
| Tradenames: | 4 |
| Applicants: | 25 |
| NDAs: | 26 |
| Drug Master File Entries: | 1472 |
| Finished Product Suppliers / Packagers: | 14 |
| Clinical Trials: | 59 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price trends for sodium nitroprusside |
| What excipients (inactive ingredients) are in sodium nitroprusside? | sodium nitroprusside excipients list |
| DailyMed Link: | sodium nitroprusside at DailyMed |
Recent Clinical Trials for sodium nitroprusside
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of Alberta | N/A |
| Assiut University | Early Phase 1 |
| Dr. Graeme Smith | Early Phase 1 |
Pharmacology for sodium nitroprusside
| Drug Class | Vasodilator |
| Physiological Effect | Vasodilation |
ATC Classes for sodium nitroprusside
US Patents and Regulatory Information for sodium nitroprusside
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Medicure | SODIUM NITROPRUSSIDE | sodium nitroprusside | INJECTABLE;INJECTION | 209584-001 | Aug 10, 2018 | AP | RX | No | No | Get Started Free | Get Started Free | Get Started Free | |||
| Mylan Labs Ltd | SODIUM NITROPRUSSIDE | sodium nitroprusside | INJECTABLE;INJECTION | 210763-001 | Apr 17, 2018 | AP | RX | No | No | Get Started Free | Get Started Free | Get Started Free | |||
| Teva Parenteral | SODIUM NITROPRUSSIDE | sodium nitroprusside | INJECTABLE;INJECTION | 073465-001 | Mar 30, 1992 | DISCN | No | No | Get Started Free | Get Started Free | Get Started Free | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2021 - 2022
NCE-1 Patent Challenge Dates 2021 - 2022
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2021, www.DrugPatentWatch.com.
Follow DrugPatentWatch:
